Personalized reference intervals: from theory to practice.

IF 6.6 2区 医学 Q1 MEDICAL LABORATORY TECHNOLOGY Critical reviews in clinical laboratory sciences Pub Date : 2022-11-01 DOI:10.1080/10408363.2022.2070905
Abdurrahman Coskun, Sverre Sandberg, Ibrahim Unsal, Mustafa Serteser, Aasne K Aarsand
{"title":"Personalized reference intervals: from theory to practice.","authors":"Abdurrahman Coskun,&nbsp;Sverre Sandberg,&nbsp;Ibrahim Unsal,&nbsp;Mustafa Serteser,&nbsp;Aasne K Aarsand","doi":"10.1080/10408363.2022.2070905","DOIUrl":null,"url":null,"abstract":"<p><p>Using laboratory test results for diagnosis and monitoring requires a reliable reference to which the results can be compared. Currently, most reference data is derived from the population, and patients in this context are considered members of a population group rather than individuals. However, such reference data has limitations when used as the reference for an individual. A patient's test results preferably should be compared with their own, individualized reference intervals (RI), i.e. a personalized RI (prRI).The prRI is based on the homeostatic model and can be calculated using an individual's previous test results obtained in a steady-state situation and estimates of analytical (CV<sub>A</sub>) and biological variation (BV). BV used to calculate the prRI can be obtained from the population (within-subject biological variation, CV<sub>I</sub>) or an individual's own data (within-person biological variation, CV<sub>P</sub>). Statistically, the prediction interval provides a useful tool to calculate the interval (i.e. prRI) for future observation based on previous measurements. With the development of information technology, the data of millions of patients is stored and processed in medical laboratories, allowing the implementation of personalized laboratory medicine. PrRI for each individual should be made available as part of the laboratory information system and should be continually updated as new test results become available.In this review, we summarize the limitations of population-based RI for the diagnosis and monitoring of disease, provide an outline of the prRI concept and different approaches to its determination, including statistical considerations for deriving prRI, and discuss aspects which must be further investigated prior to implementation of prRI in clinical practice.</p>","PeriodicalId":10760,"journal":{"name":"Critical reviews in clinical laboratory sciences","volume":"59 7","pages":"501-516"},"PeriodicalIF":6.6000,"publicationDate":"2022-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"6","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Critical reviews in clinical laboratory sciences","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/10408363.2022.2070905","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICAL LABORATORY TECHNOLOGY","Score":null,"Total":0}
引用次数: 6

Abstract

Using laboratory test results for diagnosis and monitoring requires a reliable reference to which the results can be compared. Currently, most reference data is derived from the population, and patients in this context are considered members of a population group rather than individuals. However, such reference data has limitations when used as the reference for an individual. A patient's test results preferably should be compared with their own, individualized reference intervals (RI), i.e. a personalized RI (prRI).The prRI is based on the homeostatic model and can be calculated using an individual's previous test results obtained in a steady-state situation and estimates of analytical (CVA) and biological variation (BV). BV used to calculate the prRI can be obtained from the population (within-subject biological variation, CVI) or an individual's own data (within-person biological variation, CVP). Statistically, the prediction interval provides a useful tool to calculate the interval (i.e. prRI) for future observation based on previous measurements. With the development of information technology, the data of millions of patients is stored and processed in medical laboratories, allowing the implementation of personalized laboratory medicine. PrRI for each individual should be made available as part of the laboratory information system and should be continually updated as new test results become available.In this review, we summarize the limitations of population-based RI for the diagnosis and monitoring of disease, provide an outline of the prRI concept and different approaches to its determination, including statistical considerations for deriving prRI, and discuss aspects which must be further investigated prior to implementation of prRI in clinical practice.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
个性化参考区间:从理论到实践。
使用实验室检测结果进行诊断和监测需要可靠的参考,以便对结果进行比较。目前,大多数参考数据来自人群,在这种情况下,患者被认为是一个人群群体的成员,而不是个体。然而,这些参考数据在作为个人参考时具有局限性。患者的检测结果最好与他们自己的个性化参考区间(RI)进行比较,即个性化的RI (prRI)。prRI基于稳态模型,可以使用个人在稳态情况下获得的先前测试结果以及分析(CVA)和生物变异(BV)的估计来计算。用于计算prRI的BV可以从群体(受试者内生物变异,CVI)或个人自身数据(人内生物变异,CVP)中获得。在统计上,预测区间提供了一个有用的工具来计算基于先前测量的未来观测的区间(即prRI)。随着信息技术的发展,数百万患者的数据在医学实验室中存储和处理,从而实现个性化的实验室医学。每个人的PrRI应作为实验室信息系统的一部分提供,并应在获得新的检测结果时不断更新。在这篇综述中,我们总结了基于人群的prRI在疾病诊断和监测方面的局限性,概述了prRI的概念和确定prRI的不同方法,包括推导prRI的统计考虑因素,并讨论了在临床实践中实施prRI之前必须进一步研究的方面。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
CiteScore
20.00
自引率
0.00%
发文量
25
审稿时长
>12 weeks
期刊介绍: Critical Reviews in Clinical Laboratory Sciences publishes comprehensive and high quality review articles in all areas of clinical laboratory science, including clinical biochemistry, hematology, microbiology, pathology, transfusion medicine, genetics, immunology and molecular diagnostics. The reviews critically evaluate the status of current issues in the selected areas, with a focus on clinical laboratory diagnostics and latest advances. The adjective “critical” implies a balanced synthesis of results and conclusions that are frequently contradictory and controversial.
期刊最新文献
SGLT2 inhibitors as a potential therapeutic option for pulmonary hypertension: mechanisms and clinical perspectives. Methods applied to neonatal dried blood spot samples for secondary research purposes: a scoping review. Regulatory roles of RNA methylation in vascular lesions in ocular and cardiopulmonary diseases. G protein-coupled receptor (GPCR) pharmacogenomics. Unveiling Parkinson's disease through biomarker research: current insights and future prospects.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1